Hold on to your shares: Cara Therapeutics Inc (CARA) Stock
BofA Securities lowered the price target for the Cara Therapeutics Inc (NASDAQ:CARA) stock from “a Neutral” to “an Underperform”. The rating was released on March 08, 2023, according to finviz. We previously noted in another research note published on March 08, 2022 by JP Morgan that upgraded the stock from a Neutral to an Overweight […]
If you still want to check out Cara Therapeutics Inc (CARA) Stock, you should do so again
BofA Securities lowered the price target for the Cara Therapeutics Inc (NASDAQ:CARA) stock from “a Neutral” to “an Underperform”. The rating was released on March 08, 2023, according to finviz. We previously noted in another research note published on March 08, 2022 by JP Morgan that upgraded the stock from a Neutral to an Overweight […]
